MESCOPHARM
Invest Now
Mesco Pharmaceuticals Share Price
₹00.00 0.00 (0.00%)
24 Nov, 2024 03:40
Start SIP in MESCOPHARM
Start SIPPerformance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
Investment Returns
Smart Investing Starts Here Start SIP with Mesco Pharmaceuticals for Steady Growth!
Mesco Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -2565
- PEG Ratio
- -
- Market Cap Cr
- 9
- P/B Ratio
- -
- Average True Range
- 0.19
- EPS
- -
- Dividend Yield
- -
- MACD Signal
- -0.06
- RSI
- 42.87
- MFI
- 82.03
Mesco Pharmaceuticals Financials
Mesco Pharmaceuticals Technicals
EMA & SMA
Current Price
₹00.00
(%)
- Bullish Moving Average 0
- Bearish Moving Average 0
- 20 Day
- ₹4.79
- 50 Day
- ₹5.55
- 100 Day
- -
- 200 Day
- -
Resistance and Support
4.54
- R3 4.54
- R2 4.54
- R1 4.54
- S1 4.54
- S2 4.54
- S3 4.54
Mesco Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
Date | Purpose | Remarks |
---|---|---|
2022-02-14 | Quarterly Results | |
2021-11-12 | Quarterly Results | |
2021-09-06 | Others | inter alia, 1. Appointment of Ms. Tripta. Shakya of Tripti Shakya & Co. as scrutinizer to undergo the compliance and provide scrutinizer report. |
2021-06-30 | Audited & Quarterly Results | |
2021-02-11 | Quarterly Results |
Mesco Pharmaceuticals F&O
About Mesco Pharmaceuticals
- NSE Symbol
- MESCOPHARM
- BSE Symbol
- 500274
- ISIN
- INE839X01015
Similar Stocks to Mesco Pharmaceuticals
Mesco Pharmaceuticals FAQs
Mesco Pharmaceuticals share price is ₹00 As on 24 November, 2024 | 03:26
The Market Cap of Mesco Pharmaceuticals is ₹9.2 Cr As on 24 November, 2024 | 03:26
The P/E ratio of Mesco Pharmaceuticals is -2565 As on 24 November, 2024 | 03:26
The PB ratio of Mesco Pharmaceuticals is As on 24 November, 2024 | 03:26
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.